Ravelli C - Search Results

1

Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types.

Grillo E, Ravelli C, Corsini M, Gaudenzi C, Zammataro L, Mitola S. Grillo E, et al. Among authors: ravelli c. Biochim Biophys Acta Mol Basis Dis. 2022 Feb 1;1868(2):166313. doi: 10.1016/j.bbadis.2021.166313. Epub 2021 Nov 23. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 34826586 Free article.

2

Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm.

Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M. Mitola S, et al. Among authors: ravelli c. Blood. 2008 Aug 15;112(4):1154-7. doi: 10.1182/blood-2007-09-111450. Epub 2008 May 27. Blood. 2008. PMID: 18505784 Free article.

3

Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2.

Mitola S, Ravelli C, Moroni E, Salvi V, Leali D, Ballmer-Hofer K, Zammataro L, Presta M. Mitola S, et al. Among authors: ravelli c. Blood. 2010 Nov 4;116(18):3677-80. doi: 10.1182/blood-2010-06-291930. Epub 2010 Jul 21. Blood. 2010. PMID: 20660291 Free article.

4

Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.

Chiodelli P, Mitola S, Ravelli C, Oreste P, Rusnati M, Presta M. Chiodelli P, et al. Among authors: ravelli c. Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):e116-27. doi: 10.1161/ATVBAHA.111.235184. Epub 2011 Sep 15. Arterioscler Thromb Vasc Biol. 2011. PMID: 21921258

5

Role of nanomechanics in canonical and noncanonical pro-angiogenic ligand/VEGF receptor-2 activation.

Maiolo D, Mitola S, Leali D, Oliviero G, Ravelli C, Bugatti A, Depero LE, Presta M, Bergese P. Maiolo D, et al. Among authors: ravelli c. J Am Chem Soc. 2012 Sep 5;134(35):14573-9. doi: 10.1021/ja305816p. Epub 2012 Aug 23. J Am Chem Soc. 2012. PMID: 22860754

6

Involvement of αvβ3 integrin in gremlin-induced angiogenesis.

Ravelli C, Mitola S, Corsini M, Presta M. Ravelli C, et al. Angiogenesis. 2013 Jan;16(1):235-43. doi: 10.1007/s10456-012-9309-6. Epub 2012 Sep 30. Angiogenesis. 2013. PMID: 23053782

7

Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin.

Corsini M, Moroni E, Ravelli C, Andrés G, Grillo E, Ali IH, Brazil DP, Presta M, Mitola S. Corsini M, et al. Among authors: ravelli c. Arterioscler Thromb Vasc Biol. 2014 Jan;34(1):136-45. doi: 10.1161/ATVBAHA.113.302517. Epub 2013 Nov 14. Arterioscler Thromb Vasc Biol. 2014. PMID: 24233491

8

β3 Integrin Promotes Long-Lasting Activation and Polarization of Vascular Endothelial Growth Factor Receptor 2 by Immobilized Ligand.

Ravelli C, Grillo E, Corsini M, Coltrini D, Presta M, Mitola S. Ravelli C, et al. Arterioscler Thromb Vasc Biol. 2015 Oct;35(10):2161-71. doi: 10.1161/ATVBAHA.115.306230. Epub 2015 Aug 20. Arterioscler Thromb Vasc Biol. 2015. PMID: 26293466 Free PMC article.

9

Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.

Grillo E, Ravelli C, Corsini M, Ballmer-Hofer K, Zammataro L, Oreste P, Zoppetti G, Tobia C, Ronca R, Presta M, Mitola S. Grillo E, et al. Among authors: ravelli c. Oncotarget. 2016 Jun 7;7(23):35353-68. doi: 10.18632/oncotarget.9286. Oncotarget. 2016. PMID: 27174917 Free PMC article.

10

Vascular disrupting activity of combretastatin analogues.

Porcù E, Salvador A, Primac I, Mitola S, Ronca R, Ravelli C, Bortolozzi R, Vedaldi D, Romagnoli R, Basso G, Viola G. Porcù E, et al. Among authors: ravelli c. Vascul Pharmacol. 2016 Aug;83:78-89. doi: 10.1016/j.vph.2016.05.006. Epub 2016 May 25. Vascul Pharmacol. 2016. PMID: 27235861

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page